NEW YORK (GenomeWeb News) — Genetic Technologies today said it has corrected its “brief non-compliance” with the Nasdaq exchange by appointing a director and audit committee chairman.
 
The firm appointed David Carruthers, who formerly was CFO and European regional CEO for BP Finance, and was managing director of the Treasury Corporation of Victoria, Australia.
 
Carruthers also serves on the audit committee for Ceramic Fuel Cells and is a non-executive director for India Equities Fund.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.